Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunction

PPAR Research

Volumn , Issue , 2012, Pages

  Alzamendi, Ana ^a   Giovambattista, Andrés ^a   García, María E ^b   Rebolledo, Oscar R ^b   Gagliardino, Juan J ^b   Spinedi, Eduardo ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b University of La Plata CONICET   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DRINKING WATER; FRUCTOSE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; DIETARY INTAKE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; STANDARD;

EID: 84867879701     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/259093     Document Type: Article

References (50)

1. Popkin B. M., Patterns of beverage use across the lifecycle. Physiology and Behavior 2010 100 1 4 9 2-s2.0-77950952078 10.1016/j.physbeh.2009.12.022
2. Malik V. S., Popkin B. M., Bray G. A., Després J. P., Willett W. C., Hu F. B., Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010 33 11 2477 2483 2-s2.0-78650920491 10.2337/dc10-1079
3. de Koning L., Malik V. S., Rimm E. B., Willett W. C., Hu F. B., Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. American Journal of Clinical Nutrition 2011 93 6 1321 1327 2-s2.0-79956308306 10.3945/ajcn.110.007922
4. Kohen-Avramoglu R., Theriault A., Adeli K., Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clinical Biochemistry 2003 36 6 413 420 2-s2.0-0043264144 10.1016/S0009-9120(03)00038-9
5. Verma S., Bhanot S., Yao L., McNeill J. H., Vascular insulin resistance in fructose-hypertensive rats. European Journal of Pharmacology 1997 322 2-3 R1 R2 2-s2.0-0030906039 10.1016/S0014-2999(97)00104-0
6. Hwang I. S., Ho H., Hoffman B. B., Reaven G. M., Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987 10 5 512 516 2-s2.0-0023493524
7. Basciano H., Federico L., Adeli K., Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition and Metabolism 2005 2, article 5 2-s2.0-15744394674 10.1186/1743-7075-2-5
8. United States Department of Health and Human Services and United States Department of Agriculture, Dietary Guidelines for Americans 2005 6th Washington, DC, USA United States Government Printing Office
9. Delbosc S., Paizanis E., Magous R., Araiz C., Dimo T., Cristol J. P., Cros G., Azay J., Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005 179 1 43 49 2-s2.0-13844296360 10.1016/j.atherosclerosis.2004.10.018
10. Cavarape A., Feletto F., Mercuri F., Quagliaro L., Damante G., Ceriello A., High-fructose diet decreases catalase mRNA levels in rat tissues. Journal of Endocrinological Investigation 2001 24 11 838 845 2-s2.0-0035673411
11. Faure P., Rossini E., Lafond J. L., Richard M. J., Favier A., Halimi S., Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. Journal of Nutrition 1997 127 1 103 107 2-s2.0-0031036134
12. Faure P., Rossini E., Wiernsperger N., Richard M. J., Favier A., Halimi S., An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes 1999 48 2 353 357 2-s2.0-0033008628 10.2337/diabetes.48.2.353
13. Wei Y., Wang D., Topczewski F., Pagliassotti M. J., Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. Journal of Nutritional Biochemistry 2007 18 1 1 9 2-s2.0-37849188713 10.1016/j.jnutbio.2006.03.013
14. Rebolledo O. R., Marra C. A., Raschia A., Rodriguez S., Gagliardino J. J., Abdominal adipose tissue: early metabolic dysfunction associated to insulin resistance and oxidative stress induced by an unbalanced diet. Hormone and Metabolic Research 2008 40 11 794 800 2-s2.0-57149146006 10.1055/s-2008-1081502
15. Alzamendi A., Giovambattista A., Raschia A., Madrid V., Gaillard R. C., Rebolledo O., Gagliardino J. J., Spinedi E., Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats. Endocrine 2009 35 2 227 232 2-s2.0-65549154830 10.1007/s12020-008-9143-1
16. Ashcroft S. J., Hedeskov C. J., Randle P. J., Glucose metabolism in mouse pancreatic islets. Biochemical Journal 1970 118 1 143 154 2-s2.0-0014801760
17. Giroix M. H., Scruel O., Ladriere L., Sener A., Portha B., Malaisse W. J., Metabolic and secretory interactions between D-glucose and D-fructose in islets from GK rats. Endocrinology 1999 140 12 5556 5565 2-s2.0-0033304634
18. Sener A., Malaisse W. J., Hexose metabolism in pancreatic islets. Metabolic and secretory responses to D-fructose. Archives of Biochemistry and Biophysics 1988 261 1 16 26 2-s2.0-0023878321
19. Kyriazis G. A., Soundarapandian M. M., Tyrberg B., Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion. Proceedings of the National Academy of Sciences of the United States of America 2012 109 E524 E532
20. McGuinness O. P., Cherrington A. D., Effects of fructose on hepatic glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2003 6 4 441 448 2-s2.0-9244229841 10.1097/00075197-200307000-00014
21. Hajduch E., Darakhshan F., Hundal H. S., Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes. Diabetologia 1998 41 7 821 828 2-s2.0-0031809969 10.1007/s001250050993
22. Litherland G. J., Hajduch E., Gould G. W., Hundal H. S., Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity during obesity and insulin resistance. Molecular and Cellular Biochemistry 2004 261 1 23 33 2-s2.0-3442876986 10.1023/B:MCBI.0000028734.77867. d2
23. Stanhope K. L., Griffen S. C., Bair B. R., Swarbrick M. M., Keim N. L., Havel P. J., Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. American Journal of Clinical Nutrition 2008 87 5 1194 1203 2-s2.0-43549110957
24. Stanhope K. L., Havel P. J., Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. American Journal of Clinical Nutrition 2008 88 6 1733S 1737S 2-s2.0-57449088882 10.3945/ajcn.2008.25825D
25. Stanhope K. L., Havel P. J., Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Current Opinion in Lipidology 2008 19 1 16 24 2-s2.0-38149042079 10.1097/MOL.0b013e3282f2b24a
26. Ye J. M., Doyle P. J., Iglesias M. A., Watson D. G., Cooney G. J., Kraegen E. W., Peroxisome proliferator-activated receptor (PPAR)- α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats. Comparison with PPAR- γ activation. Diabetes 2001 50 2 411 417 2-s2.0-0035141142
27. Collino M., Aragno M., Castiglia S., Miglio G., Tomasinelli C., Boccuzzi G., Thiemermann C., Fantozzi R., Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. British Journal of Pharmacology 2010 160 8 1892 1902 2-s2.0-77954880936 10.1111/j.1476-5381.2010.00671.x
28. Minoura H., Takeshita S., Kimura J., Hirosumi J., Takakura S., Kawamura I., Seki J., Manda T., Mutoh S., Mechanism by which a novel non- thiazolidinedione peroxisome proliferator-activated receptor γ agonist, FK614, ameliorates insulin resistance in Zucker fatty rats. Diabetes, Obesity and Metabolism 2007 9 3 369 378 2-s2.0-33947643121 10.1111/j.1463-1326.2006. 00619.x
29. Alzamendi A., Castrogiovanni D., Ortega H. H., Gaillard R. C., Giovambattista A., Spinedi E., Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats. Obesity 2010 18 3 441 448 2-s2.0-77249100724 10.1038/oby.2009.255
30. Giovambattista A., Chisari A. N., Gaillard R. C., Spinedi E., Food intake-induced leptin secretion modulates hypothalamo-pituitary-adrenal axis response and hypothalamic Ob-Rb expression to insulin administration. Neuroendocrinology 2000 72 6 341 349 2-s2.0-0034502901 10.1159/000054603
31. Moreno G., Perelló M., Camihort G., Luna G., Console G., Gaillard R. C., Spinedi E., Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rats. International Journal of Obesity 2006 30 1 73 82 2-s2.0-29044438904 10.1038/sj.ijo.0803109
32. Chomczynski P., Sacchi N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 1 156 159 2-s2.0-0023277545
33. McElroy W. D., Swanson C. P., Biostatistical Analysis 1974 Englewood Cliffs, NJ, USA Prentice Hall-Englewood
34. Grundy S. M., Hansen B., Smith S. C., Cleeman J. I., Kahn R. A., Clinical management of metabolic syndrome: report of the American Heart Association/National heart, lung, and blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management. Circulation 2004 109 4 551 556 2-s2.0-0842285784 10.1161/01.CIR.0000112379.88385.67
35. Miatello R., Vázquez M., Renna N., Cruzado M., Zumino A. P., Risler N., Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. American Journal of Hypertension 2005 18 6 864 870 2-s2.0-19744369830 10.1016/j.amjhyper.2004.12.012
36. Walder K., Filippis A., Clark S., Zimmet P., Collier G. R., Leptin inhibits insulin binding in isolated rat adipocytes. Journal of Endocrinology 1997 155 3 R5 R7 2-s2.0-0030782649
37. Cohen B., Novick D., Rubinstein M., Modulation of insulin activities by leptin. Science 1996 274 5290 1185 1188 2-s2.0-0029860791 10.1126/science.274. 5290.1185
38. Pérez C., Fernández-Galaz C., Fernández- Agulló T., Arribas C., Andrés A., Ros M., Carrascosa J. M., Leptin impairs insulin signaling in rat adipocytes. Diabetes 2004 53 2 347 353 2-s2.0-0842331606 10.2337/diabetes.53.2.347
39. de Souza C. J., Eckhardt M., Gagen K., Dong M., Chen W., Laurent D., Burkey B. F., Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001 50 8 1863 1871 2-s2.0-0035430576
40. Smith U., Gogg S., Johansson A., Olausson T., Rotter V., Svalstedt B., Thiazolidinediones (PPAR γ agonists) but not PPAR α agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes. The FASEB Journal 2001 15 1 215 220 2-s2.0-0035172839 10.1096/fj.00-0020com
41. Iwata M., Haruta T., Usui I., Takata Y., Takano A., Uno T., Kawahara J., Ueno E., Sasaoka T., Ishibashi O., Kobayashi M., Pioglitazone ameliorates tumor necrosis factor- α -induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor- γ Diabetes 2001 50 5 1083 1092 2-s2.0-0035029255
42. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615
43. Iida K. T., Kawakami Y., Suzuki M., Shimano H., Toyoshima H., Sone H., Shimada K., Iwama Y., Watanabe Y., Mokuno H., Kamata K., Yamada N., Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. American Journal of Physiology 2003 284 6 E1125 E1130 2-s2.0-0038177982
44. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
45. Dobrian A. D., Schriver S. D., Khraibi A. A., Prewitt R. L., Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 2004 43 1 48 56 2-s2.0-0346157985 10.1161/01.HYP.0000103629.01745. 59
46. Okuno Y., Matsuda M., Kobayashi H., Morita K., Suzuki E., Fukuhara A., Komuro R., Shimabukuro M., Shimomura I., Adipose expression of catalase is regulated via a novel remote PPAR γ -responsive region. Biochemical and Biophysical Research Communications 2008 366 3 698 704 2-s2.0-37549042853 10.1016/j.bbrc.2007.12.001
47. Laurora S., Pizzimenti S., Briatore F., Fraioli A., Maggio M., Reffo P., Ferretti C., Dianzani M. U., Barrera G., Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. Journal of Pharmacology and Experimental Therapeutics 2003 305 3 932 942 2-s2.0-0037799843 10.1124/jpet.103.049098
48. Chopra B., Georgopoulos N. T., Nicholl A., Hinley J., Oleksiewicz M. B., Southgate J., Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels. Cell Proliferation 2009 42 5 688 700 2-s2.0-69549133613 10.1111/j.1365-2184.2009. 00628.x
49. Barbieri M., Di Filippo C., Esposito A., Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR- γ -knockout (CM-PGKO) mice. PLoS ONE 2012 7 4 e35999
50. Matthews L., Berry A., Tersigni M., D'Acquisto F., Ianaro A., Ray D., Thiazolidinediones are partial agonists for the glucocorticoid receptor. Endocrinology 2009 150 1 75 86 2-s2.0-58149461547 10.1210/en.2008-0196